LLY•benzinga•
Novo Nordisk Stock Sinks To 52-Week Lows: Weight Loss Boom Losing Steam?
Summary
Novo Nordisk is betting on the future with a $2-billion deal to buy rights to a Chinese obesity drug. But investors remain unimpressed.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 26, 2025 by benzinga